Filing Details
- Accession Number:
- 0001543407-17-000028
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-08-11 09:57:22
- Reporting Period:
- 2017-08-10
- Filing Date:
- 2017-08-11
- Accepted Time:
- 2017-08-11 09:57:22
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
10795 | Becton Dickinson & Co | BDX | Surgical & Medical Instruments & Apparatus (3841) | 220760120 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1575385 | R Ellen Strahlman | C/O Becton, Dickinson And Company 1 Becton Drive Franklin Lakes NJ 07417 | Senior Vice President | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2017-08-10 | 20,601 | $108.89 | 26,638 | No | 4 | M | Direct | |
Common Stock | Disposition | 2017-08-10 | 11,318 | $198.21 | 15,320 | No | 4 | D | Direct | |
Common Stock | Disposition | 2017-08-10 | 9,283 | $198.21 | 6,037 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | D | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Appreciation Rights | Disposition | 2017-08-10 | 20,601 | $0.00 | 20,601 | $108.89 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
6,869 | 2014-11-26 | 2023-11-26 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 4,816 | Indirect | See footnote |
Footnotes
- The reported sale price reflects the weighted average sale price for multiple transactions. The actual sales prices for the transactions ranged from $198 through $198.45. Full information regarding the number of shares purchased at each separate price will be provided to the Securities and Exchange Commission, the issuer or a security holder of the issuer upon request.
- The stock appreciation rights vest in four annual installments beginning November 26, 2014.
- By trust for benefit of reporting person's children of which reporting person is trustee.